摘要
目的:观察法舒地尔联合曲美他嗪治疗冠心病(CHD)慢性心力衰竭(CHF)的疗效及安全性。方法:CHD CHF患者(58例)随机分为对照组(常规基础药物治疗)、曲美他嗪组(常规+曲美他嗪)和联合治疗组(常规+曲美他嗪+法舒地尔)。治疗3个月后观察3组心功能、心室重构的变化。结果:与曲美他嗪和对照组比,联合治疗组心功能分级、6 min步行试验及对心脏重塑的改善明显(P<0.05)。结论:在常规治疗的基础上,法舒地尔联合曲美他嗪能显著改善CHD CHF患者的心功能和心室重构。
Objective:To investigate the effect of fasudil hydrochloride combined with trimetazidine in the treatment of patients with chronic heart failure(CHF)caused by coronary heart disease(CHD). Methods:A total of 58 patients with CHF caused by CHD were randomly divided into control(common treatment),trimetazidine(common treatment+trimetazidine) and combined treatment(common treatment+trimetazidine+fasudil hydrochloride)groups. The heart function and ventricular remodeling among groups were observed for 3 months after treatment. Results:Compared with control and trimetazidine groups,the cardiac functional grading,6-minute walking test and ventricular remodeling were obviously improved in the combined treatment group(P〈0.05). Conclusion:Base on the basic treatment,fasudil hydrochloride combined with trimetazidine can improve the heart function and ventricular remodeling in patients with CHF caused by CHD.
出处
《汕头大学医学院学报》
2015年第4期206-208,共3页
Journal of Shantou University Medical College
关键词
法舒地尔
曲美他嗪
冠心病
心力衰竭
心室重构
fasudil hydrochloride
trimetazidine
coronary heart disease
heart failure
ventricular remodeling